Literature DB >> 21380618

Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis.

Jingyu Deng1, Han Liang, Dan Sun, Yi Pan, Yong Liu, Dianchang Wang.   

Abstract

BACKGROUND: The superiority of extended lymphadenectomy for the prognosis of gastric cancer (GC) is still controversial. The authors hypothesized that extended lymphadenectomy could improve the overall survival (OS) of GC patients with a specific extent of lymph node metastasis.
METHODS: Data from 456 GC patients who underwent curative gastrectomy with lymphadenectomy were used to illuminate the difference of OS between patients who underwent limited lymphadenectomy and patients who underwent extended lymphadenectomy.
RESULTS: As a whole, there was no significant difference of OS between patients who underwent extended lymphadenectomy and patients who underwent limited lymphadenectomy in all 456 GC patients. However, we demonstrated that extended lymphadenectomy significantly improved the OS of GC patients with perigastric lymph node metastasis (n1 stage based on the Japanese Gastric Cancer Association classification) compared to limited lymphadenectomy (P = 0.023). Furthermore, the more the negative lymph nodes were, the longer the OS of GC patients with perigastric node metastasis following extended lymphadenectomy was (P < 0.001).
CONCLUSIONS: Extensive lymph node dissection and good harvest of negative lymph nodes should be deemed as the most important factors to improve the OS of GC patients with perigastric node metastasis.

Entities:  

Mesh:

Year:  2011        PMID: 21380618     DOI: 10.1007/s00423-011-0753-3

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  35 in total

1.  The new Japanese Classification of Gastric Carcinoma: Points to be revised.

Authors:  Takashi Aiko; Mitsuru Sasako
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

Review 2.  Radical surgery for gastric cancer. A review of the Japanese experience.

Authors:  Y Noguchi; T Imada; A Matsumoto; D G Coit; M F Brennan
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

3.  Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

4.  Risk factors predictive of lymph node metastasis in depressed early gastric cancer.

Authors:  Nobutsugu Abe; Takashi Watanabe; Kazufumi Suzuki; Hiromichi Machida; Hiroshi Toda; Yuzo Nakaya; Tadahiko Masaki; Toshiyuki Mori; Masanori Sugiyama; Yutaka Atomi
Journal:  Am J Surg       Date:  2002-02       Impact factor: 2.565

5.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

Review 6.  Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer.

Authors:  Henk H Hartgrink; Cornelis J H van de Velde
Journal:  J Surg Oncol       Date:  2005-06-01       Impact factor: 3.454

7.  Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma.

Authors:  H Katai; K Yoshimura; K Maruyama; M Sasako; T Sano
Journal:  Cancer       Date:  2000-04-15       Impact factor: 6.860

8.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

9.  Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.

Authors:  M Degiuli; M Sasako; M Calgaro; M Garino; F Rebecchi; M Mineccia; D Scaglione; D Andreone; A Ponti; F Calvo
Journal:  Eur J Surg Oncol       Date:  2004-04       Impact factor: 4.424

10.  Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.

Authors:  Hiroaki Saito; Tomohiro Osaki; Daiki Murakami; Teruhisa Sakamoto; Shingo Kanaji; Shotaro Ohro; Shigeru Tatebe; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  Hepatogastroenterology       Date:  2007-03
View more
  9 in total

1.  Effects of extended lymphadenectomy and postoperative chemotherapy on node-negative gastric cancer.

Authors:  Qiang Xue; Xiao-Na Wang; Jing-Yu Deng; Ru-Peng Zhang; Han Liang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy.

Authors:  Jingyu Deng; Rupeng Zhang; Yuan Pan; Baogui Wang; Liangliang Wu; Xishan Hao; Han Liang
Journal:  Tumour Biol       Date:  2013-11-29

Review 3.  Clinical significance of lymph node metastasis in gastric cancer.

Authors:  Jing-Yu Deng; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

4.  Prognosis of patients with gastric cancer and solitary lymph node metastasis.

Authors:  Chun-Qiu Chen; Xiao-Jiang Wu; Zhen Yu; Zhao-De Bu; Ke-Qiang Zuo; Zi-Yu Li; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

5.  Significant differences in the clinicopathological characteristics and survival of gastric cancer patients from two cancer centers in china and Korea.

Authors:  Zhan Long Shen; Kyo Young Song; Ying Jiang Ye; Qi Wei Xie; Bin Liang; Kewei Jiang; Cho Hyun Park; Shan Wang
Journal:  J Gastric Cancer       Date:  2015-03       Impact factor: 3.720

6.  Ratio between negative and positive lymph nodes is suitable for evaluation the prognosis of gastric cancer patients with positive node metastasis.

Authors:  Jingyu Deng; Dan Sun; Yuan Pan; Li Zhang; Rupeng Zhang; Dianchang Wang; Xishan Hao; Han Liang
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

7.  Negative node count improvement prognostic prediction of the seventh edition of the TNM classification for gastric cancer.

Authors:  Jingyu Deng; Rupeng Zhang; Li Zhang; Yong Liu; Xishan Hao; Han Liang
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

8.  Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer.

Authors:  Jingyu Deng; Han Liang; Guoguang Ying; Rupeng Zhang; Baogui Wang; Jun Yu; Daiming Fan; Xishan Hao
Journal:  Oncotarget       Date:  2014-05-30

9.  Impact of the number of examined lymph nodes on stage migration in node-negative gastric cancer patients: a Chinese multi-institutional analysis with propensity score matching.

Authors:  Pengfei Gu; Jingyu Deng; Wei Wang; Zhenning Wang; Zhiwei Zhou; Huimian Xu; Han Liang
Journal:  Ann Transl Med       Date:  2020-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.